Observations on the eosinophilia of certain patients with rheumatoid arthritis.
D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D003168:Complement Fixation Tests; D004802:Eosinophilia / Q000150:complications* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D005260:Female; D005356:Fibromyalgia / Q000209:etiology; D005455:Fluorescent Antibody Technique; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D002479:Inclusion Bodies; D008175:Lung Neoplasms / Q000150:complications; D008297:Male; D008875:Middle Aged; D009443:Neuritis / Q000209:etiology; D010493:Pericarditis / Q000209:etiology; D011241:Prednisone / Q000627:therapeutic use; D011658:Pulmonary Fibrosis / Q000209:etiology; D012189:Retrospective Studies; D012217:Rheumatoid Factor / Q000032:analysis; D012218:Rheumatoid Nodule / Q000209:etiology; D012883:Skin Ulcer / Q000209:etiology; D013997:Time Factors
D007074:Immunoglobulin G; D007075:Immunoglobulin M; D012217:Rheumatoid Factor; D011241:Prednisone